
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
| Revenue (TTM) | $201.11B |
| Gross Profit (TTM) | $52.27B |
| EBITDA | $8.32B |
| Operating Margin | 4.56% |
| Return on Equity | 11.10% |
| Return on Assets | 3.83% |
| Revenue/Share (TTM) | $912.91 |
| Book Value | $206.99 |
| Price-to-Book | 1.93 |
| Price-to-Sales (TTM) | 0.43 |
| EV/Revenue | 0.535 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -13.10% |
| Quarterly Revenue Growth (YoY) | 1.40% |
| Shares Outstanding | $216.87M |
| Float | $216.41M |
| % Insiders | 0.19% |
| % Institutions | 94.02% |
Volatility is currently contracting

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

INDIANAPOLIS--(BUSINESS WIRE)--Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.Each year in the U.S., 1.8 million people are diagnosed with cancer. For many patients, a cancer diagnosis brings not only medical decisions, but also a comp.

Delta Air Lines was a contributor during the quarter. Fuel prices spiked in March following the onset of the Iran War, creating a near-term headwind for airline profitability. Intercontinental Exchange stock price declined due to market concerns about AI disruption and potential competition from new exchanges launching perpetual futures. We were pleased to initiate a position in Equitable Holdings at a meaningful discount to intrinsic value.

Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript

Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.

Elevance Health NYSE: ELV raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management's expectations, citing favorable benefit expense performance, disciplined cost management and improving execution across several major business lines.

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elevance Health (ELV) came out with quarterly earnings of $7.45 per share, beating the Zacks Consensus Estimate of $6.18 per share. This compares to earnings of $8.84 per share a year ago.

Elevance Health reported second quarter net income of $1.45 billion as medical costs fell in some health plans, triggering an improved outlook for the rest of the year.

The health insurer raised its earnings outlook after logging a higher benefit-expense ratio and sales number in the second quarter.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ELV and any ticker you trade — then tracks every position and per-strategy win rate.